J&J/Closure Liquiderm Distribution Pact Includes OTC Wound Care Platform
This article was originally published in The Gray Sheet
Executive Summary
Closure Medical's worldwide distribution agreement with Johnson & Johnson for the Liquiderm over-the-counter liquid adhesive bandage includes an over-the-counter wound care pipeline based on the platform technology.
You may also be interested in...
Closure Medical's Liquiderm Bandage Clearance Opens $1 Bil. Market
Closure Medical hopes to seal a distribution agreement for its Liquiderm over-the-counter liquid adhesive bandage by mid-year. The product's 510(k) clearance by FDA was announced Jan. 31.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.